Back to search

The Open University

Matrix Metalloproteinase Activation and Inhibition

Abstract

dc:description.abstract

Processes leading to the <i>in vitro</i> activation of progelatinase-A, progelatinase-B and procollagenase were examined. Progelatinase-A can be activated by treatment with 4-aminophenyl mercuric acetate or by matrilysin and collagenase. The former induces an intramolecular self-cleavage before further intermolecular cleavages generate the mature enzyme. Whilst matrilysin can process progelatinase-A to the mature form, collagenase can only generate an intermediate by cleaving after N<sub>37</sub> in the bait region. This intermediate is identical to that produced by a human tumour cell-line in culture. Gelatinase-A reciprocates the action of collagenase by completing the activation of the latter to generate a form of collagenase with full collagenolytic activity. This has been described as superactivation and is commonly associated with the action of stromelysin. It correlates with the appearance of F<sub>81</sub> at the amino-terminus. <br></br><br></br> The C-terminal domain plays no role in catalysis but may be important for <i>in vivo</i> activity. This is particularly evident for collagenase which loses the ability to cleave collagen in its absence. The interaction between collagenase and collagen was shown to be a potential target for designing inhibitors of collagen breakdown. <br></br><br></br> The properties of a series of reversible, competitive hydroxamic acid matrix metalloproteinase inhibitors were studied. Incorporation of a phenylpropyi group in the P<sub>1</sub>' position produced inhibitors with picomolar affinities for the gelatinases and discriminated against collagenase and matrilysin and other classes of zinc metallopeptidases. The high affinity of these inhibitors for gelatinase-A was shown to derive from a combination of diffusion limited association rates and very slow dissociation rates. <br></br><br></br> Methods were developed to allow the study of the pharmacokinetic properties of these inhibitors. Chemical modifications at the P<sub>2</sub>’ and P<sub>3</sub>’ positions were shown to result in inhibitors with oral bioavailabilities of greater than 30% in the mouse.

Degree

thesis:*
Name dc:type.qualificationname
phd
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
The Open University
Year dc:date.issued
1995

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • O'Connell, James Philip

Rights

Language dc:language
en

Chain of custody

source
Harvested from
The Open University
Base URL
oro.open.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

O'Connell, James Philip. Matrix Metalloproteinase Activation and Inhibition. doctoral thesis, The Open University, 1995.